EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity

Eslam Roshdy iD, Ahmet Kilic, Muhamad Mustafa iD, Ismail Celik iD, Zeynep Betül Sarı, Ender Simsek, Alessio Nocentini iD, Simone Giovannuzzi iD, Claudiu T Supuran iD, Özen Özensoy Güler, Jean-Yves Winum iD, Manabu Abe iD

Journal of Medicinal Chemistry · 14.05.2026 · 69 (9) · 11365-11381

DOI: 10.1021/acs.jmedchem.6c00547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 30.04.2026. Verfasst von Eslam Roshdy und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 73…. Hauptthemen laut MEDLINE: Sulfonamides, Carbonic Anhydrase Inhibitors, Triazoles, Carbonic Anhydrase IX. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Core Research for Evolutional Science and Technology, Erciyes Üniversitesi, Support for Pioneering Research Initiated by the Next Generation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbonic anhydrase hCA IX and hCA XII are cancer-associated enzymes involved in tumor pH regulation, hypoxia-driven survival, and therapeutic resistance. Here, we report the rational design, synthesis, and biological evaluation of bis-triazole-linked benzenesulfonamides as novel carbonic anhydrase inhibitors. Several compounds exhibited potent and selective inhibition of hCA IX/XII, with compounds 2g and 4g showing nanomolar activity (hCA IX KI = 25.1 and 28.1 nM; hCA XII KI = 35.2 and 11.6 nM, respectively) and reduced activity against off-target isoforms hCA I/II, indicating favorable selectivity profiles. Lead compounds 2g and 4g significantly enhanced the antiproliferative effects of azacitidine and sorafenib in breast and pancreatic cancer cells under both normoxic and hypoxic conditions. Molecular modeling and simulation studies further supported productive zinc coordination and stable active-site interactions. Overall, these findings highlight bis-triazole benzenesulfonamides as promising scaffolds for targeting hCA IX/XII-expressing tumors and improving chemosensitivity to conventional chemotherapeutics to overcome cancer resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesCarbonic Anhydrase InhibitorsTriazolesCarbonic Anhydrase IXDrug DesignCarbonic AnhydrasesAntineoplastic AgentsHumansBenzenesulfonamidesStructure-Activity RelationshipCell Line, TumorCell ProliferationAntigens, NeoplasmModels, Molecular

Substanzen

SulfonamidesCarbonic Anhydrase InhibitorsTriazolesCarbonic Anhydrase IXBenzenesulfonamidesCarbonic Anhydrasescarbonic anhydrase XIIAntineoplastic AgentsCA9 protein, humanAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8526, Japan.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
  • Department of Medical Biology, Faculty of Medicine, Ankara Yildirim Beyazit University (AYBU), 06800 Ankara, Turkey.
  • IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Erciyes University, Kayseri 38039, Turkey.
  • Yenimahalle Education and Research Training Hospital, Yenimahalle, Ankara 06370, Turkey.

ORCID-Profile: Eslam Roshdy, Muhamad Mustafa, Ismail Celik, Alessio Nocentini, Simone Giovannuzzi, Claudiu T Supuran, Jean-Yves Winum, Manabu Abe

Förderung

  • Core Research for Evolutional Science and Technology
  • Erciyes Üniversitesi
  • Support for Pioneering Research Initiated by the Next Generation

Zitieren

APA

Roshdy, E., Kilic, A., Mustafa, M., Celik, I., Sarı, Z. B., Simsek, E., Nocentini, A., Giovannuzzi, S., Supuran, C. T., Özensoy Güler, Ö., Winum, J. Y., & Abe, M. (2026). Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity. Journal of Medicinal Chemistry, 69(9), 11365-11381. https://doi.org/10.1021/acs.jmedchem.6c00547

Vancouver

Roshdy E, Kilic A, Mustafa M, Celik I, Sarı ZB, Simsek E, et al. Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity. Journal of Medicinal Chemistry. 2026;69(9):11365-11381. doi:10.1021/acs.jmedchem.6c00547

BibTeX
@article{Roshdy2026,
  author = {Roshdy, Eslam and Kilic, Ahmet and Mustafa, Muhamad and Celik, Ismail and Sarı, Zeynep Betül and Simsek, Ender and Nocentini, Alessio and Giovannuzzi, Simone and Supuran, Claudiu T and Özensoy Güler, Özen and Winum, Jean-Yves and Abe, Manabu},
  title = {Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {9},
  pages = {11365--11381},
  doi = {10.1021/acs.jmedchem.6c00547}
}
Kostenlos starten →